Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fuji
US Army
Daiichi Sankyo
AstraZeneca
Farmers Insurance

Generated: September 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021812

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 021812 describes WOMEN'S ROGAINE, which is a drug marketed by Johnson And Johnson and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the WOMEN'S ROGAINE profile page.

The generic ingredient in WOMEN'S ROGAINE is minoxidil. There are eight drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the minoxidil profile page.
Summary for 021812
Tradename:WOMEN'S ROGAINE
Applicant:Johnson And Johnson
Ingredient:minoxidil
Patents:1
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021812
Suppliers and Packaging for NDA: 021812
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812 NDA Johnson & Johnson Consumer Inc. 69968-0030 69968-0030-1 1 CAN in 1 CARTON (69968-0030-1) > 60 g in 1 CAN
MEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812 NDA Johnson & Johnson Consumer Inc. 69968-0030 69968-0030-2 2 CAN in 1 CARTON (69968-0030-2) > 60 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:AEROSOL, FOAM;TOPICALStrength5%
Approval Date:Jan 20, 2006TE:RLD:Yes
Patent:  Try a Free TrialPatent Expiration:Apr 20, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL AEROSOL HAIR REGROWTH TREATMENT

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:AEROSOL, FOAM;TOPICALStrength5%
Approval Date:Feb 28, 2014TE:RLD:Yes
Patent:  Try a Free TrialPatent Expiration:Apr 20, 2019Product Flag?YSubstance Flag?Delist Request?
Patented Use:TOPICAL AEROSOL HAIR REGROWTH TREATMENT

Expired US Patents for NDA 021812

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Johnson And Johnson MEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-001 Jan 20, 2006   Try a Free Trial   Try a Free Trial
Johnson And Johnson WOMEN'S ROGAINE minoxidil AEROSOL, FOAM;TOPICAL 021812-002 Feb 28, 2014   Try a Free Trial   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
UBS
McKinsey
Citi
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.